Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Cannabist Co Holdings (CBSTF) Change in Receivables (2021 - 2025)

Cannabist Co Holdings (CBSTF) has disclosed Change in Receivables for 5 consecutive years, with -$3.2 million as the latest value for Q3 2025.

  • Quarterly Change in Receivables fell 1518.5% to -$3.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Sep 2025, up 176.0% year-over-year, with the annual reading at $13.4 million for FY2024, 385.52% up from the prior year.
  • Change in Receivables hit -$3.2 million in Q3 2025 for Cannabist Co Holdings, down from $2.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $11.3 million in Q3 2023 to a low of -$12.9 million in Q4 2023.
  • Historically, Change in Receivables has averaged $635789.5 across 5 years, with a median of $227000.0 in 2024.
  • Biggest five-year swings in Change in Receivables: surged 675.76% in 2023 and later crashed 1518.5% in 2025.
  • Year by year, Change in Receivables stood at $5.7 million in 2021, then crashed by 145.01% to -$2.6 million in 2022, then crashed by 405.82% to -$12.9 million in 2023, then soared by 164.48% to $8.3 million in 2024, then tumbled by 138.57% to -$3.2 million in 2025.
  • Business Quant data shows Change in Receivables for CBSTF at -$3.2 million in Q3 2025, $2.0 million in Q2 2025, and -$1.1 million in Q1 2025.